Correlation Between FarGlory Hotel and GeneFerm Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both FarGlory Hotel and GeneFerm Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FarGlory Hotel and GeneFerm Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FarGlory Hotel Co and GeneFerm Biotechnology Co, you can compare the effects of market volatilities on FarGlory Hotel and GeneFerm Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FarGlory Hotel with a short position of GeneFerm Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of FarGlory Hotel and GeneFerm Biotechnology.

Diversification Opportunities for FarGlory Hotel and GeneFerm Biotechnology

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between FarGlory and GeneFerm is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding FarGlory Hotel Co and GeneFerm Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneFerm Biotechnology and FarGlory Hotel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FarGlory Hotel Co are associated (or correlated) with GeneFerm Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneFerm Biotechnology has no effect on the direction of FarGlory Hotel i.e., FarGlory Hotel and GeneFerm Biotechnology go up and down completely randomly.

Pair Corralation between FarGlory Hotel and GeneFerm Biotechnology

Assuming the 90 days trading horizon FarGlory Hotel Co is expected to under-perform the GeneFerm Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, FarGlory Hotel Co is 2.04 times less risky than GeneFerm Biotechnology. The stock trades about -0.1 of its potential returns per unit of risk. The GeneFerm Biotechnology Co is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  5,480  in GeneFerm Biotechnology Co on April 7, 2024 and sell it today you would earn a total of  1,030  from holding GeneFerm Biotechnology Co or generate 18.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

FarGlory Hotel Co  vs.  GeneFerm Biotechnology Co

 Performance 
       Timeline  
FarGlory Hotel 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days FarGlory Hotel Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, FarGlory Hotel is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
GeneFerm Biotechnology 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in GeneFerm Biotechnology Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, GeneFerm Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

FarGlory Hotel and GeneFerm Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with FarGlory Hotel and GeneFerm Biotechnology

The main advantage of trading using opposite FarGlory Hotel and GeneFerm Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FarGlory Hotel position performs unexpectedly, GeneFerm Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneFerm Biotechnology will offset losses from the drop in GeneFerm Biotechnology's long position.
The idea behind FarGlory Hotel Co and GeneFerm Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance